Anna Wasiuk, Ph.D.

Affiliations: 
2010 Immunology and Microbiology Dartmouth College, Hanover, NH, United States 
Area:
Immunology, Cell Biology
Google:
"Anna Wasiuk"

Parents

Sign in to add mentor
Randolph J. Noelle grad student 2010 Dartmouth
 (Bridging the adaptive and innate immune system: A study on mast cells and the regulation of tumor immunity.)
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Nowak EC, de Vries VC, Wasiuk A, et al. (2012) Tryptophan hydroxylase-1 regulates immune tolerance and inflammation. The Journal of Experimental Medicine. 209: 2127-35
Wasiuk A, Dalton DK, Schpero WL, et al. (2012) Mast cells impair the development of protective anti-tumor immunity. Cancer Immunology, Immunotherapy : Cii. 61: 2273-82
Wang L, Rubinstein R, Lines JL, et al. (2011) VISTA, a novel mouse Ig superfamily ligand that negatively regulates T cell responses. The Journal of Experimental Medicine. 208: 577-92
Wasiuk A, De Vries VC, Nowak EC, et al. (2010) Mast cells in allergy and tumor disease Cancer and Ige: Introducing the Concept of Allergooncology. 137-158
de Vries VC, Wasiuk A, Bennett KA, et al. (2009) Mast cell degranulation breaks peripheral tolerance. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 9: 2270-80
Elgueta R, Benson MJ, de Vries VC, et al. (2009) Molecular mechanism and function of CD40/CD40L engagement in the immune system. Immunological Reviews. 229: 152-72
Wasiuk A, de Vries VC, Hartmann K, et al. (2009) Mast cells as regulators of adaptive immunity to tumours. Clinical and Experimental Immunology. 155: 140-6
Lind EF, Ahonen CL, Wasiuk A, et al. (2008) Dendritic cells require the NF-kappaB2 pathway for cross-presentation of soluble antigens. Journal of Immunology (Baltimore, Md. : 1950). 181: 354-63
Ahonen CL, Wasiuk A, Fuse S, et al. (2008) Enhanced efficacy and reduced toxicity of multifactorial adjuvants compared with unitary adjuvants as cancer vaccines. Blood. 111: 3116-25
See more...